Zobrazeno 1 - 6
of 6
pro vyhledávání: '"John Phillips III"'
Autor:
Ravi Savarirayan, William Wilcox, Paul Harmatz, John Phillips, III, Lynda Polgreen, Louise Tofts, Keiichi Ozono, Paul Arundel, Melita Irving, Carlos Bacino, Donald Basel, Ricki Carroll, Joel Charrow, Hiroshi Mochizuki, Yumiko Kotani, Howard Saal, Lingling Han, Andrea Low, Elena Fisheleva, Jonathan Day
Publikováno v:
Genetics in Medicine Open, Vol 2, Iss , Pp 101028- (2024)
Externí odkaz:
https://doaj.org/article/848e38cda46d4c7a890843f69282c6c4
Autor:
Julie Hoover-Fong, Melita Irving, Carlos Bacino, Joel Charrow, Carlos Prada, Valerie Cormier-Daire, Lynda Polgreen, Paul Harmatz, Sajda Ghani, Elena Fisheleva, Andrea Low, Jonathan Day, John Phillips, III, Ravi Savarirayan
Publikováno v:
Genetics in Medicine Open, Vol 2, Iss , Pp 101041- (2024)
Externí odkaz:
https://doaj.org/article/f3aedeb68bbf4a27b0ecec698a216bfa
Autor:
Daniela Rogoff, Josep Maria De Bergua, Ravi Savarirayan, Paul Arundel, Jean Pierre Salles, Antonio Leiva-Gea, Melita Irving, Vrinda Saraff, Helen McDevitt, Fernando Santos-Simarro, Marc Nicolino, Valerie Cormier-Daire, Peter Kannu, Mars Skae, Michael B Bober, John Phillips III, Christine Burren, Paul Harmatz, Howard Saal, Julie Hoover-Fong, Elena Muslimova, Terry Cho, Richard Weng
Publikováno v:
Journal of the Endocrine Society. 6:A632-A633
Background Achondroplasia (ACH) is the most common short-limbed skeletal dysplasia, affecting between 1 in 15,000 to 1 in 30,000 live births. Children and adults with ACH have disproportionate short stature and are at risk for several significant co-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69684a5b210f279f5ff19e008ee34677
https://doi.org/10.1210/jendso/bvac150.1310
https://doi.org/10.1210/jendso/bvac150.1310
Autor:
Ravi Savarirayan, William W Wilcox, Paul Harmatz, John Phillips III, Lynda E Polgreen, Louise Tofts, Keiichi Ozono, Paul Arundel, Melita Irving, Carlos A Bacino, Donald Basel, Michael B Bober, Joel Charrow, Hiroshi Mochizuki, Yumiko Kotani, Howard M Saal, George Jeha, Lynn Han, Elena Fisheleva, Alice Huntsman-Labed, Jonathan Day
Publikováno v:
Journal of the Endocrine Society. 6:A591-A592
Background Vosoritide increases annualized growth velocity (AGV) in children with achondroplasia aged 5 to 18 years. This global, phase 2, randomized, double-blind, placebo-controlled study evaluated the safety and efficacy of vosoritide on growth in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0641d06d71e5365785cd672e557acacf
https://doi.org/10.1210/jendso/bvac150.1225
https://doi.org/10.1210/jendso/bvac150.1225
Autor:
Melita Irving, Josep Maria De Bergua, Daniela Rogoff, Ravi Savarirayan, Paul Arundel, Jean Pierre Salles, Antonio Leiva-Gea, Vrinda Saraff, Helen McDevitt, Fernando Santos-Simarro, Marc Nicolino, Valerie Cormier-Daire, Peter Kannu, Mars Skae, Michael B Bober, John Phillips III, Christine Burren, Paul Harmatz, Howard Saal, Julie Hoover-Fong, Richard Weng, Elena Muslimova, Terry Cho
Publikováno v:
Journal of the Endocrine Society. 6:A644-A644
Background Achondroplasia (ACH) is the most common short-limbed skeletal dysplasia, affecting between 1 in 15,000 to 1 in 30,000 live births. People with ACH are at risk for several significant co-morbidities, including foramen magnum stenosis, obstr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2d3e3c0a7c39cf013737fe1cf3deea1
https://doi.org/10.1210/jendso/bvac150.1332
https://doi.org/10.1210/jendso/bvac150.1332
Autor:
Elena Muslimova, Josep Maria De Bergua, Ravi Savarirayan, Paul Arundel, Helen McDevitt, Valerie Cormier-Daire, Vrinda Saraff, Mars Skae, Borja Delgado, Antonio Leiva-Gea, Fernando Santos-Simarro, Jean Pierre Salles, Marc Nicolino, Massimiliano Rossi, Peter Kannu, Michael B Bober, John Phillips III, Howard Saal, Paul Harmatz, Christine Burren, Garrett Gotway, Terry Cho, Richard Weng, Daniela Rogoff, Julie Hoover-Fong, Melita Irving
Publikováno v:
Journal of the Endocrine Society. 6:A633-A633
Background Achondroplasia (ACH), the most common non-lethal form of skeletal dysplasia, is characterized by defective endochondral ossification resulting from gain-of-function mutations in the fibroblast growth factor receptor 3 (FGFR3) gene, a negat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1bafeb87050fd1f69e9d253070e954d
https://doi.org/10.1210/jendso/bvac150.1311
https://doi.org/10.1210/jendso/bvac150.1311